ARV Stock Overview
Arvida Group Limited, together with its subsidiaries, owns, develops, and operates retirement villages and care facilities for the elderly in New Zealand.
Arvida Group Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||NZ$1.43|
|52 Week High||NZ$2.14|
|52 Week Low||NZ$1.39|
|1 Month Change||-5.30%|
|3 Month Change||-1.38%|
|1 Year Change||-31.58%|
|3 Year Change||-1.38%|
|5 Year Change||15.32%|
|Change since IPO||50.53%|
Recent News & Updates
Results: Arvida Group Limited Beat Earnings Expectations And Analysts Now Have New Forecasts
Arvida Group Limited ( NZSE:ARV ) came out with its annual results last week, and we wanted to see how the business is...
An Intrinsic Calculation For Arvida Group Limited (NZSE:ARV) Suggests It's 21% Undervalued
Does the May share price for Arvida Group Limited ( NZSE:ARV ) reflect what it's really worth? Today, we will estimate...
|ARV||NZ Healthcare||NZ Market|
Return vs Industry: ARV underperformed the NZ Healthcare industry which returned -22.2% over the past year.
Return vs Market: ARV underperformed the NZ Market which returned -17.6% over the past year.
|ARV Average Weekly Movement||3.0%|
|Healthcare Industry Average Movement||3.8%|
|Market Average Movement||3.9%|
|10% most volatile stocks in NZ Market||7.7%|
|10% least volatile stocks in NZ Market||2.8%|
Stable Share Price: ARV is less volatile than 75% of NZ stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: ARV's weekly volatility (3%) has been stable over the past year.
About the Company
Arvida Group Limited, together with its subsidiaries, owns, develops, and operates retirement villages and care facilities for the elderly in New Zealand. As of March 31, 2022, it operated approximately 35 retirement villages with 1,544 aged care beds and 3,912 retirement units. The company was formerly known as Hercules Limited.
Arvida Group Fundamentals Summary
|ARV fundamental statistics|
Is ARV overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|ARV income statement (TTM)|
|Cost of Revenue||NZ$140.72m|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
|Earnings per share (EPS)||0.27|
|Net Profit Margin||98.62%|
How did ARV perform over the long term?See historical performance and comparison
4.2%Current Dividend Yield
Is ARV undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 5/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ARV?
Other financial metrics that can be useful for relative valuation.
|What is ARV's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does ARV's PE Ratio compare to its peers?
|ARV PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
OCA Oceania Healthcare
SUM Summerset Group Holdings
RYM Ryman Healthcare
RAD Radius Residential Care
ARV Arvida Group
Price-To-Earnings vs Peers: ARV is good value based on its Price-To-Earnings Ratio (5.2x) compared to the peer average (13.5x).
Price to Earnings Ratio vs Industry
How does ARV's PE Ratio compare vs other companies in the Global Healthcare Industry?
Price-To-Earnings vs Industry: ARV is good value based on its Price-To-Earnings Ratio (5.2x) compared to the Global Healthcare industry average (17.3x)
Price to Earnings Ratio vs Fair Ratio
What is ARV's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||5.2x|
|Fair PE Ratio||4.8x|
Price-To-Earnings vs Fair Ratio: ARV is expensive based on its Price-To-Earnings Ratio (5.2x) compared to the estimated Fair Price-To-Earnings Ratio (4.8x).
Share Price vs Fair Value
What is the Fair Price of ARV when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: ARV (NZ$1.43) is trading below our estimate of fair value (NZ$2.02)
Significantly Below Fair Value: ARV is trading below fair value by more than 20%.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.
Discover undervalued companies
How is Arvida Group forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?
Future Growth Score1/6
Future Growth Score 1/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ARV's earnings are forecast to decline over the next 3 years (-38.4% per year).
Earnings vs Market: ARV's earnings are forecast to decline over the next 3 years (-38.4% per year).
High Growth Earnings: ARV's earnings are forecast to decline over the next 3 years.
Revenue vs Market: ARV's revenue (13.2% per year) is forecast to grow faster than the NZ market (5.6% per year).
High Growth Revenue: ARV's revenue (13.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ARV's Return on Equity is forecast to be low in 3 years time (8%).
Discover growth companies
How has Arvida Group performed over the past 5 years?
Past Performance Score4/6
Past Performance Score 4/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ARV has a large one-off gain of NZ$188.9M impacting its March 31 2022 financial results.
Growing Profit Margin: ARV's current net profit margins (98.6%) are higher than last year (75.2%).
Past Earnings Growth Analysis
Earnings Trend: ARV's earnings have grown significantly by 27.9% per year over the past 5 years.
Accelerating Growth: ARV's earnings growth over the past year (51.7%) exceeds its 5-year average (27.9% per year).
Earnings vs Industry: ARV earnings growth over the past year (51.7%) exceeded the Healthcare industry 12.7%.
Return on Equity
High ROE: ARV's Return on Equity (14.8%) is considered low.
Discover strong past performing companies
How is Arvida Group's financial position?
Financial Health Score2/6
Financial Health Score 2/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: ARV's short term assets (NZ$67.8M) do not cover its short term liabilities (NZ$1.5B).
Long Term Liabilities: ARV's short term assets (NZ$67.8M) do not cover its long term liabilities (NZ$579.4M).
Debt to Equity History and Analysis
Debt Level: ARV's net debt to equity ratio (33.9%) is considered satisfactory.
Reducing Debt: ARV's debt to equity ratio has increased from 19.9% to 34.5% over the past 5 years.
Debt Coverage: ARV's debt is well covered by operating cash flow (32.7%).
Interest Coverage: ARV's interest payments on its debt are not well covered by EBIT (1.4x coverage).
Discover healthy companies
What is Arvida Group current dividend yield, its reliability and sustainability?
Dividend Score 3/6
Cash Flow Coverage
Current Dividend Yield
Dividend Yield vs Market
|Arvida Group Dividend Yield vs Market|
|Company (Arvida Group)||4.2%|
|Market Bottom 25% (NZ)||2.8%|
|Market Top 25% (NZ)||6.3%|
|Industry Average (Healthcare)||2.7%|
|Analyst forecast in 3 Years (Arvida Group)||4.9%|
Notable Dividend: ARV's dividend (4.2%) is higher than the bottom 25% of dividend payers in the NZ market (2.86%).
High Dividend: ARV's dividend (4.2%) is low compared to the top 25% of dividend payers in the NZ market (6.13%).
Stability and Growth of Payments
Stable Dividend: Whilst dividend payments have been stable, ARV has been paying a dividend for less than 10 years.
Growing Dividend: ARV's dividend payments have increased, but the company has only paid a dividend for 7 years.
Earnings Payout to Shareholders
Earnings Coverage: With its low payout ratio (17%), ARV's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (31.9%), ARV's dividend payments are well covered by cash flows.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mr. Jeremy Nicoll, BCom, CA serves as Chief Executive Officer at Arvida Group Limited since 2021 and was Deputy Chief Executive Officer until 2021. He served as the Chief Financial Officer of Arvida Grou...
Experienced Management: ARV's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.
Experienced Board: ARV's board of directors are considered experienced (7.3 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
|02 May 22||BuyNZ$23,379,018||Forsyth Barr Investment Management Limited||Company||12,529,038||NZ$1.87|
|02 May 22||SellNZ$11,576,168||Forsyth Barr Investment Management Limited||Company||6,471,490||NZ$1.79|
|02 May 22||BuyNZ$16,346,491||Forsyth Barr Investment Management Limited||Company||8,340,050||NZ$1.96|
|18 Oct 21||BuyNZ$28,987,113||Milford Asset Management Limited||Company||14,743,582||NZ$1.97|
|18 Oct 21||SellNZ$16,148,907||Milford Asset Management Limited||Company||7,765,504||NZ$2.08|
|18 Oct 21||BuyNZ$121,520||Paul Ridley-Smith||Individual||62,000||NZ$1.96|
|Owner Type||Number of Shares||Ownership Percentage|
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 33.2%.
|Ownership||Name||Shares||Current Value||Change %||Portfolio %|
Arvida Group Limited's employee growth, exchange listings and data sources
- Name: Arvida Group Limited
- Ticker: ARV
- Exchange: NZSE
- Founded: 2014
- Industry: Health Care Facilities
- Sector: Healthcare
- Implied Market Cap: NZ$1.035b
- Shares outstanding: 723.58m
- Website: https://www.arvida.co.nz
Number of Employees
- Arvida Group Limited
- 39 Market Place
- Level 1
- New Zealand
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|ARV||NZSE (New Zealand Stock Exchange)||Yes||Ordinary Shares||NZ||NZD||Dec 2014|
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/09/28 00:00|
|End of Day Share Price||2022/09/28 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.